Fagerholm, Rainer <br/><br/>
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.  [electronic resource] 

 -  Oncotarget  Mar 2017 
 - 18381-18398 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.15110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anthracyclines--therapeutic use<br/>Apoptosis Regulatory Proteins--genetics<br/>Breast Neoplasms--genetics<br/>Female<br/>Genotype<br/>Humans<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Quantitative Trait Loci<br/>SKP Cullin F-Box Protein Ligases--genetics<br/>Survival Analysis<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--genetics<br/>Young Adult